| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Fox Christine | EVP, Head of U.S. Commercial | C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, ISRAEL | /s/ Dov Bergwerk as attorney-in-fact for Christine Fox | 18 Nov 2025 | 0001998173 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TEVA | Ordinary Shares | Sale | $753,321 | -30,000 | -51% | $25.11 | 28,384 | 14 Nov 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |